SIVANANDHAN; Dhanalakshmi

Patent Applications and Registrations

Patent applications and USPTO patent grants for SIVANANDHAN; Dhanalakshmi.The latest application filed is for "cyclopropyl-amide compounds as dual lsd1/hdac inhibitors".

Company Profile

7.7.12

SIVANANDHAN; Dhanalakshmi - Yeshwanthpur Bangalore IN
Sivanandhan; Dhanalakshmi - Bangalore IN
Sivanandhan; Dhanalakshmi - Noida IN

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Cyclopropyl-amide Compounds As Dual Lsd1/hdac Inhibitors App 20220281815 - RAJAGOPAL; Sridharan ; et al.	2022-09-08
Cyclopropyl-amide compounds as dual LSD1/HDAC inhibitors Grant 11,352,322 - Rajagopal , et al. June 7, 2	2022-06-07
Tricyclic fused derivatives of 1-(cyclo)alkyl pyrtdin-2-one useful for the treatment of cancer Grant 11,319,326 - Vadivelu , et al. May 3, 2	2022-05-03
Tricyclic fused pyridin-2-one derivatives and their use as BRD4 inhibitors Grant 11,267,820 - Vadivelu , et al. March 8, 2	2022-03-08
Method And Compound For Use, In Treating And/or Preventing Netosis App 20220047569 - Kazmi; Syed M I ; et al.	2022-02-17
Heterocyclic Compounds As Prmt5 Inhibitors App 20210371431 - VADIVELU; Saravanan ; et al.	2021-12-02
Bicyclic Compounds As Inhibitors Of Pd1/pd-l1 Interaction/activation App 20210015810 - VENKATESHAPPA; Chandregowda ; et al.	2021-01-21
Tricyclic Fused Pyridin-2-one Derivatives And Their Use As Brd4 Inhibitors App 20200339595 - VADIVELU; Saravanan ; et al.	2020-10-29
Tricyclic Fused Derivatives Of 1-(cyclo)alkyl Pyridin-2-one Useful For The Treatment Of Cancer App 20200331926 - Vadivelu; Saravanan ; et al.	2020-10-22
Cyclopropyl-amide Compounds As Dual Lsd1/hdac Inhibitors App 20200308110 - RAJAGOPAL; Sridharan ; et al.	2020-10-01
Tricyclic fused pyridin-2-one derivatives and their use as BRD4 inhibitors Grant 10,689,395 - Vadivelu , et al.	2020-06-23
Tricyclic fused derivatives of 1-(cyclo)alkyl pyridin-2-one useful for the treatment of cancer Grant 10,689,390 - Vadivelu , et al.	2020-06-23
Substituted pyrimidine compounds, compositions and medicinal applications thereof Grant 10,273,224 - Venkateshappa , et al.	2019-04-30
Tricyclic Fused Derivatives Of 1-(cyclo)alkyl Pyridin-2-one Useful For The Treatment Of Cancer App 20180282345 - VADIVELU; Saravanan ; et al.	2018-10-04
Tricyclic Fused Pyridin-2-one Derivatives And Their Use As Brd4 Inhibitors App 20180237453 - VADIVELU; Saravanan ; et al.	2018-08-23
Compounds For Regulating Fak And/or Src Pathways App 20160222014 - Venkatesan; Aranapakam M. ; et al.	2016-08-04
Substituted Pyrimidine Compounds, Compositions And Medicinal Applications Thereof App 20160207905 - VENKATESHAPPA; CHANDREGOWDA ; et al.	2016-07-21
Biaryl imidazole derivatives for regulating CYP17 Grant 9,199,975 - Smith , et al. December 1, 2	2015-12-01
Imidazole Derivatives App 20130085164 - Smith; Roger Astbury ; et al.	2013-04-04

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.